Skip to main content

Table 1 Effect of eculizumab on liver function

From: Eculizumab in paroxysmal nocturnal hemoglobinuria with Budd-Chiari syndrome progressing despite anticoagulation

Days post-eculizumab

Laboratory value (normal range)

 

LDH

Platelets

Hemoglobin

AST

ALT

Bilirubin total

Bilirubin D

Cholinesterase

Albumin

 

U/L

× 10 9/L

g/dL

U/L

U/L

mg/dL

mg/dL

U/L

g/dL

 

(≤480)

(150–400)

(14–18)

(≤40)

(≤37)

(0.2–1.3)

(<0.3)

(>4400)

(3.5–5.0)

-68

1836

34

9.2

63

78

3.6

1.7

3572

-33

921

27

9.8

49

70

2.4

0.9

2889

3.47

0 (1st dose)

23

10.7

36

24

3.3

1.4

7

519

53

9.7

20

18

2.3

1

3.54

14

368

57

10.3

15

14

1.9

0.7

56

565

80

9.6

28

9

2.2

1

5135

3.6

119

248

53

9.9

16

8

1.7

0.8

5975

202

295

94

11.3

25

20

2.1

0.9

6968

4.52

300

344

62

10.3

28

25

1.6

0.6

7603

4.68

365

298

58

10.2

22

19

1.6

0.7

4.27

449

354

69

11.3

26

26

1.9

0.8

7704

5.1

547

340

63

12

25

24

1.6

0.6

7852

4.73

631

285

73

11.6

26

27

1.8

0.7

8360

743

351

65

11.5

26

23

1.7

0.7

8294

4.46

827

388

64

11.2

26

22

1.4

0.6

921

423

77

12.6

28

25

1.9

0.6

4.49

  1. ALT, alanine aminotransferase; AST, aspartate aminotransferase.